A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Cefacetrile | CAS 10206-21-0 - Request Quote

Picture of Cefacetrile
SZ CAT No:SZ-C162001
CAS No
10206-21-0
Mol.F.
C13H13N3O6S
Mol.Wt.
339.3
Inv. Status
Synthesis on demand
Rel. CAS No23239-41-0 (Na salt)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Cefacetrile is chemically (6R,7R)-3-(acetoxymethyl)-7-(2-cyanoacetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Cefacetrile is supplied with detailed characterization data compliant with regulatory guideline. Cefacetrile can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefacetrile.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 10206-21-0

Purchase 10206-21-0

Order 10206-21-0

Enquire 10206-21-0

price of 10206-21-0

10206-21-0 Supplier

10206-21-0 Manufacturer

10206-21-0 Exporter

buy high quality Cefacetrile

Purchase Cefacetrile

Cefacetrile suppliers

Cefacetrile manufacturers

Cefacetrile price

Order Cefacetrile

Enquire Cefacetrile

Cefacetrile cost

Cefacetrile Supplier

Cefacetrile Distributor

Cefacetrile for Method Validation

Cefacetrile Reference Standard

Cefacetrile for ANDA Filing

Cefacetrile for Forced Degradation Studies

Cefacetrile Identification Standards

Cefacetrile for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,